CLL Treatment Decision Tool The CLL Society worked with Clinical Care Options or CCO whose mission is “to improve clinical care and patient health...
Clonal Heterogeneity Take Away Points: Cancer by its nature is genomic unstable. Over time it acquires more mutations. New clones and sub-clones can arise over...
Individualized Therapy Take Away Points: Every one of us with CLL has a different type of CLL that may behave differently. The biology of...
Predictive and Prognostic Markers in CLL Take Away Points: Prognostic markers help predict the likely outcome of cancer for a group, but less so for any...
Prognostic Indicators Part 2 This is a follow up to Prognostic Indicators (Part 1) that should be reviewed first. Take Away Points: There has been an...
Why your doctor is always going FISH-ing: The importance of Del 17p and other chromosomal changes. By Michael Choi, MD It is a tremendous understatement to say that one should not take a “one-size fits all”...
